FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

766549006: Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension (clinical drug)


Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3692049016 Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension en Synonym Active Initial character case insensitive SNOMED CT core
3692050016 Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
3692052012 Danthron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension en Synonym Active Initial character case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Plays role Laxative therapeutic role true Inferred relationship Some
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Plays role Stool softener therapeutic role false Inferred relationship Some
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Is a Dantron and poloxamer 188 only product in oral dose form true Inferred relationship Some
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has manufactured dose form Oral suspension true Inferred relationship Some
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Is a Dantron- and poloxamer 188-containing product in oral dose form false Inferred relationship Some
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength denominator unit mL true Inferred relationship Some 1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has precise active ingredient Danthron true Inferred relationship Some 1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Count of base of active ingredient 2 false Inferred relationship Some
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength denominator unit mL true Inferred relationship Some 2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength numerator unit mg true Inferred relationship Some 1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has precise active ingredient Poloxamer 188 true Inferred relationship Some 2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has BoSS Danthron true Inferred relationship Some 1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength denominator value 1 false Inferred relationship Some 1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength denominator value 1 false Inferred relationship Some 2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength numerator unit mg true Inferred relationship Some 2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has BoSS Poloxamer 188 true Inferred relationship Some 2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength numerator value 200 false Inferred relationship Some 2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Has concentration strength numerator value 15 false Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start